IL59793A - Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(1-pyridinium-methyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them - Google Patents

Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(1-pyridinium-methyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them

Info

Publication number
IL59793A
IL59793A IL59793A IL5979379A IL59793A IL 59793 A IL59793 A IL 59793A IL 59793 A IL59793 A IL 59793A IL 5979379 A IL5979379 A IL 5979379A IL 59793 A IL59793 A IL 59793A
Authority
IL
Israel
Prior art keywords
ceph
aminothiazol
oxyimino
acetamido
pyridinium
Prior art date
Application number
IL59793A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL59793A publication Critical patent/IL59793A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
IL59793A 1978-05-26 1979-05-25 Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(1-pyridinium-methyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them IL59793A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2291378 1978-05-26
GB2291178 1978-05-26
IL57400A IL57400A (en) 1978-05-26 1979-05-25 (6r,7r)-7-((z)-2-(2-aminothiazol-4-yl-2(2-carboxyprop-2-oxyimino)acetamido)-3-(1-pyridiniummethyl)ceph-3-em-4-carboxylic acid and its derivatives,process for their preparation and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
IL59793A true IL59793A (en) 1982-08-31

Family

ID=26256190

Family Applications (3)

Application Number Title Priority Date Filing Date
IL59793A IL59793A (en) 1978-05-26 1979-05-25 Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(1-pyridinium-methyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them
IL57400A IL57400A (en) 1978-05-26 1979-05-25 (6r,7r)-7-((z)-2-(2-aminothiazol-4-yl-2(2-carboxyprop-2-oxyimino)acetamido)-3-(1-pyridiniummethyl)ceph-3-em-4-carboxylic acid and its derivatives,process for their preparation and pharmaceutical compositions comprising them
IL59793A IL59793A0 (en) 1978-05-26 1980-04-09 Cephalosporin antibiotics

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL57400A IL57400A (en) 1978-05-26 1979-05-25 (6r,7r)-7-((z)-2-(2-aminothiazol-4-yl-2(2-carboxyprop-2-oxyimino)acetamido)-3-(1-pyridiniummethyl)ceph-3-em-4-carboxylic acid and its derivatives,process for their preparation and pharmaceutical compositions comprising them
IL59793A IL59793A0 (en) 1978-05-26 1980-04-09 Cephalosporin antibiotics

Country Status (27)

Country Link
US (2) US4258041A (xx)
AR (2) AR228726A1 (xx)
AT (1) AT370420B (xx)
AU (1) AU524671B2 (xx)
CA (1) CA1127633A (xx)
CH (2) CH646178A5 (xx)
DE (1) DE2921316C2 (xx)
DK (1) DK157685C (xx)
ES (2) ES480914A1 (xx)
FI (2) FI67555C (xx)
FR (2) FR2426695A1 (xx)
HK (1) HK40183A (xx)
IE (2) IE49172B1 (xx)
IL (3) IL59793A (xx)
IT (1) IT1116198B (xx)
KE (1) KE3252A (xx)
LU (1) LU81319A1 (xx)
MY (1) MY8400017A (xx)
NL (2) NL176855C (xx)
NO (2) NO155347C (xx)
NZ (2) NZ190558A (xx)
PH (1) PH16961A (xx)
PT (2) PT69670A (xx)
SE (2) SE438507B (xx)
SG (1) SG58382G (xx)
SI (2) SI7911231A8 (xx)
YU (2) YU41635B (xx)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963542A (en) * 1976-09-08 1990-10-16 Takeda Chemical Industries, Ltd. Cephalosporin derivatives
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides
DE3019838A1 (de) * 1979-05-25 1980-12-04 Glaxo Group Ltd Zwischenprodukte zur verwendung bei der herstellung von cephalosporin-antibiotika
BE885488A (fr) * 1979-10-02 1981-04-01 Glaxo Group Ltd Bischlorhydrate de cephalosporine et sa preparation
CH645906A5 (de) * 1979-10-02 1984-10-31 Glaxo Group Ltd Cephalosporinantibiotika.
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
US4338313A (en) * 1979-10-12 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4332800A (en) * 1979-10-12 1982-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
FR2476647A2 (fr) * 1980-02-26 1981-08-28 Roussel Uclaf Procede de preparation de derives de l'acide 2-(2-amino protege 4-thiazolyl) 2-alkoxyimino acetique isomere syn
US4252802A (en) * 1980-03-13 1981-02-24 E. R. Squibb & Sons, Inc. Hydroxamic acid derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins
GR75711B (xx) * 1980-06-30 1984-08-02 Sanofi Sa
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE3175156D1 (en) * 1980-08-29 1986-09-25 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
FR2494276A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
US4427677A (en) 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JPS57144291A (en) * 1981-03-02 1982-09-06 Ajinomoto Co Inc Preparation of imidazoledicarboxylic acid derivative
US4336253A (en) * 1981-03-11 1982-06-22 Eli Lilly And Company Cephalosporin antibiotics
JPS6011917B2 (ja) * 1981-04-09 1985-03-28 山之内製薬株式会社 新規なセファロスポリン化合物
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
GR75487B (xx) * 1981-06-22 1984-07-23 Fujisawa Pharmaceutical Co
US4406898A (en) * 1981-09-08 1983-09-27 Eli Lilly And Company Oxazole and oxadiazole cephalosporins
US4382932A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company Isoquinolinium substituted cephalosporins
US4436912A (en) 1981-09-08 1984-03-13 Eli Lilly And Company 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido cephalosporin antibiotics and intermediates therefor
US4577014A (en) * 1981-09-08 1986-03-18 Eli Lilly And Company Thieno and furopyridinium-substituted cephalosporins
US4430499A (en) 1981-09-08 1984-02-07 Eli Lilly And Company 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido]cephalosporin antibiotics
US4382931A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company 3'-Substituted quinolinium cephalosporins
JPS5859991A (ja) * 1981-09-14 1983-04-09 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物
US4401668A (en) * 1981-10-02 1983-08-30 Eli Lilly And Company Pyrazinium substituted cephalosporins
US4388316A (en) * 1981-10-02 1983-06-14 Eli Lilly And Company Amino-substituted oxazole, oxadiazole and isoxazole-substituted cephalosporins
US4379787A (en) * 1981-10-02 1983-04-12 Eli Lilly And Company Oximino-substituted cephalosporin compounds
US4402955A (en) * 1981-10-02 1983-09-06 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4450270A (en) * 1981-10-02 1984-05-22 Eli Lilly And Company Dioximino cephalosporin antibiotics
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
JPS58109477A (ja) * 1981-11-13 1983-06-29 グラクソ・グル−プ・リミテツド 新規な化合物
EP0088847B1 (en) * 1981-11-13 1986-02-26 Glaxo Group Limited Thiazole derivatives and their use in the manufacture of beta-lactam antibiotics
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
US4394503A (en) * 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
US4501739A (en) * 1982-01-19 1985-02-26 Eli Lilly And Company Thieno and furopyridinium-substituted cephalosporins
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
DE3375013D1 (en) * 1982-04-29 1988-02-04 Glaxo Group Ltd Thiazole derivative, process for its preparation and use in the preparation of beta-lactam antibiotics
EP0097961B1 (en) 1982-06-28 1987-11-11 Bristol-Myers Company Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
ES8502863A1 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
EP0113568B1 (en) * 1982-12-27 1990-04-04 Eli Lilly And Company Intermediates for the preparation of ceftazidine, and process for their preparation
EP0115770B2 (en) * 1983-01-07 1996-06-19 Takeda Chemical Industries, Ltd. Thiazole Derivatives
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3316798A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
US4540779A (en) * 1983-06-20 1985-09-10 Eli Lilly And Company Crystalline 7-(R)-amino-3-(1'pyridiniummethyl)-ceph-3-em-4-carboxylate monohydrochloride monohydrate compound
US4497811A (en) * 1983-07-01 1985-02-05 Seiji Shibahara 1-Oxadethiacephalosporin compound and antibacterial agent containing the _same
JPS6061528A (ja) * 1983-09-09 1985-04-09 ブリストル―マイヤーズ　スクイブ　カンパニー 嫌気性菌を包含する耐性バクテリアの処理法
AU566944B2 (en) * 1983-10-07 1987-11-05 Gist-Brocades N.V. Preparation of 3-cephem derivatives
JPS60178891A (ja) * 1984-02-24 1985-09-12 Kureha Chem Ind Co Ltd セファロスポリン誘導体及び該誘導体を含有する医薬
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
US4788185A (en) * 1984-04-23 1988-11-29 Takeda Chemical Industries, Ltd. Cephalosporin compounds
PH22107A (en) * 1984-06-07 1988-06-01 Takeda Chemical Industries Ltd 3-pyrazolo(1,5-a)pyrdinium cephem compounds
CA1236089A (en) * 1984-06-25 1988-05-03 Perry C. Heath Ceftazidime
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
IL76367A0 (en) * 1984-09-17 1986-01-31 Lilly Co Eli Improved process for cephalsporin intermediates
US4659813A (en) * 1984-11-08 1987-04-21 Eli Lilly And Company Crystallization process for ceftazidime derivative
GB8504072D0 (en) * 1985-02-18 1985-03-20 Fujisawa Pharmaceutical Co Cephem compounds
ATE89826T1 (de) * 1985-03-01 1993-06-15 Takeda Chemical Industries Ltd Antibakterielle verbindungen, ihre herstellung und verwendung.
US4703118A (en) * 1985-04-08 1987-10-27 Eli Lilly And Company Synthesis of 3-iodomethyl cephalosporins
US4692518A (en) * 1985-11-06 1987-09-08 Eli Lilly And Company Crystalline (7R)-7-amino-3-(1'-pyridiniummethyl)-3-cephem-4-carboxylate monohydrate compound
JPS62175489A (ja) * 1986-01-29 1987-08-01 Sanwa Kagaku Kenkyusho:Kk 新規なセフアロスポリン誘導体及びその塩、これらの製法並びに該化合物を有効成分とする感染症治療剤
US5359057A (en) * 1986-02-07 1994-10-25 Hoffmann-La Roche Inc. Acylation of amines
JPS63107989A (ja) * 1986-06-04 1988-05-12 Tanabe Seiyaku Co Ltd セファロスポリン化合物
AT387022B (de) * 1986-06-04 1988-11-25 Biochemie Gmbh Verfahren zur herstellung einer neuen kristallinen form eines cefalosporinderivats
IL82738A0 (en) * 1986-06-16 1987-12-20 Tanabe Seiyaku Co Cephalosporin compounds,their preparation and pharmaceutical compositions containing them
EP0282531B1 (de) * 1986-09-10 1992-04-15 Biochemie Gesellschaft M.B.H. Stabile, kristalline form eines cefalosporin-zwischenproduktes
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
ES2032543T3 (es) * 1987-02-02 1993-02-16 Eli Lilly And Company Procedimiento mejorado de preparacion de un antibiotico.
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
KR950010084B1 (ko) * 1987-06-25 1995-09-06 반유세이야꾸 가부시끼가이샤 결정성 세팔로스포린 화합물, 그의 제조법 및 그의 제조 중간체
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
EP0377987A3 (en) * 1988-12-27 1991-08-28 Eli Lilly And Company Acylation process for obtaining cephalosporin derivatives
US5194604A (en) * 1990-06-29 1993-03-16 E. R. Squibb & Sons, Inc. Process and intermediates for beta-lactams having aminothiazole(iminooxyacetic acid)acetic acid sidechains
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
US5281589A (en) * 1991-06-15 1994-01-25 Cheil Foods & Chemicals, Inc. 3-fused pyridiniummethyl cephalosporins
KR100194994B1 (ko) * 1993-06-05 1999-06-15 손경식 새로운 세펨 화합물
US6472383B1 (en) 1994-04-25 2002-10-29 Smithkline Beecham P.L.C. Pharmaceutical formulations
PL179415B1 (pl) * 1994-04-25 2000-09-29 Smithkline Beecham Plc Preparat farmaceutyczny do leczenia zakazen bakteryjnych i sposób wytwarzania preparatu farmaceutycznego do leczenia zakazen bakteryjnych PL PL
JPH09506112A (ja) * 1994-05-23 1997-06-17 コリア・インスティチュート・オブ・サイアンス・アンド・テクノロジー セファロスポリン化合物およびその製造方法
US5831085A (en) * 1997-01-16 1998-11-03 Lupin Laboratories Limited Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
IN189047B (xx) 1998-06-01 2002-12-14 Ranbaxy Lab Ltd
US6930983B2 (en) * 2000-03-15 2005-08-16 Texas Instruments Incorporated Integrated circuits, systems, apparatus, packets and processes utilizing path diversity for media over packet applications
KR100342600B1 (ko) 2000-03-06 2002-07-04 한미정밀화학주식회사 신규한 티아졸 화합물 및 그의 제조 방법
KR100392409B1 (ko) 2000-03-20 2003-07-22 한미정밀화학주식회사 신규한 티아졸 화합물을 이용한 세팔로스포린계항생물질의 제조 방법
US6911441B2 (en) * 2002-12-16 2005-06-28 Akzo Nobel N.V. Prolonged release pharmaceutical composition
CN1312158C (zh) * 2005-05-20 2007-04-25 天津市医药集团技术发展有限公司 一种头孢克肟的制备方法
EP2209474A4 (en) 2007-10-09 2013-07-24 Sopharmia Inc BROAD SPECTRUM BETA-LACTAMASE INHIBITORS
CN101293891B (zh) * 2008-06-12 2011-01-12 齐鲁安替制药有限公司 头孢他啶中间体的制备方法
EP2753326A4 (en) 2011-09-09 2015-04-15 Cubist Pharm Inc METHOD FOR THE TREATMENT OF INTRAPULMONARY INFECTIONS
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
GEP20186874B (en) 2013-03-13 2018-06-25 Biopharma Antibiotics Ip Llc Theravance Hydrochloride salts of an antibiotic compound
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
PE20160048A1 (es) 2013-03-15 2016-02-12 Merck Sharp & Dohme Composiciones antibioticas de ceftolozano
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN106336418B (zh) * 2016-08-19 2019-02-01 上海上药新亚药业有限公司 一种头孢他啶盐酸盐的固相合成法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017515A (en) * 1971-05-14 1977-04-12 Glaxo Laboratories Limited α-(Etherified oximino) carboxylic acids and acid chlorides
US4024133A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-,furyl- or pyridylacetamido)]cephalosporins
GB1399086A (en) 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4064346A (en) * 1971-05-14 1977-12-20 Glaxo Laboratories Limited 3-Acetoxymethyl-7β-(2-carboxy-methoxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
US4079178A (en) * 1971-05-14 1978-03-14 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino) acylamido groups at the 7-position
US4024137A (en) * 1971-05-14 1977-05-17 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US4091209A (en) * 1971-05-14 1978-05-23 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(phenyl or naphthylacetamido)]cephalosporins having a 2-haloalkylcarbamoyloxymethyl group at the 3-position
US4033950A (en) * 1971-05-14 1977-07-05 Glaxo Laboratories Limited 3-Hydroxymethyl-7β-(2-alkoxy-or benzyloxyimino-2-arylacetamido)ceph-3-em-4-carboxylic acids and salts thereof
GB1496757A (en) 1973-12-21 1978-01-05 Glaxo Lab Ltd Cephalosporin derivatives
US4144392A (en) * 1973-12-21 1979-03-13 Glaxo Laboratories Limited Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
US4095021A (en) * 1973-12-21 1978-06-13 Glaxo Laboratories Limited 3-Carbamoyloxymethyl or N-methyl-carbamoyloxymethyl-7-[2-carboxymethoxyimino-2-(fur-2-yl or thien-2-yl)acetamido]ceph-3-em-4-carboxylic acids and derivatives thereof
US4060686A (en) * 1973-12-21 1977-11-29 Janice Bradshaw Cephalosporins having a 7-(carboxy substituted α-etherified oximinoarylacetamido) group
US4162360A (en) * 1973-12-21 1979-07-24 Glaxo Laboratories Limited 3-Carbamoyloxymethyl-7-substituted oximino acetamido cephalosporanic acid derivatives
US4032950A (en) * 1974-12-06 1977-06-28 Hughes Aircraft Company Liquid phase epitaxial process for growing semi-insulating gaas layers
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4165430A (en) * 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
JPS52125188A (en) 1976-04-14 1977-10-20 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
ZA781502B (en) 1977-03-14 1979-09-26 Fujisawa Pharmaceutical Co New cephem and cepham compounds and processes for preparation thereof
FR2384782A1 (fr) 1977-03-25 1978-10-20 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
HU184680B (en) 1977-04-02 1984-09-28 Hoechst Ag Process for producing ceph-3-eme-4-carboxylic acid derivatives containing amino-thiazolyl group in the side chain
DE2716677C2 (de) 1977-04-15 1985-10-10 Hoechst Ag, 6230 Frankfurt Cephemderivate und Verfahren zu ihrer Herstellung
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
GB1602725A (en) 1977-04-27 1981-11-18 Glaxo Operations Ltd 7-(a-oxyiminoacetamido)-ceph-3-em-4-carboxylic acid derivatives
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
US4237128A (en) * 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides
US4394503A (en) * 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
KE3252A (en) 1983-01-28
DK157685C (da) 1990-07-09
DE2921316A1 (de) 1979-12-06
DK216779A (da) 1979-11-27
SG58382G (en) 1983-09-02
ATA239281A (de) 1982-08-15
YU41635B (en) 1987-12-31
YU223482A (en) 1983-04-30
CH646178A5 (de) 1984-11-15
NO155347B (no) 1966-12-08
IE802453L (en) 1979-11-26
DK157685B (da) 1990-02-05
CA1127633A (en) 1982-07-13
FR2426695B1 (xx) 1982-06-11
SI8212234A8 (en) 1997-06-30
US4258041A (en) 1981-03-24
SE8402887L (sv) 1984-05-28
SE7904576L (sv) 1980-02-11
MY8400017A (en) 1984-12-31
IL57400A0 (en) 1979-09-30
NL176855C (nl) 1985-06-17
NL8001348A (nl) 1980-06-30
PT69670A (en) 1979-06-01
PH16961A (en) 1984-04-27
AR228726A1 (es) 1983-04-15
FR2445835A1 (fr) 1980-08-01
AR229883A1 (es) 1983-12-30
FI67705B (fi) 1985-01-31
IE791025L (en) 1979-11-26
AU524671B2 (en) 1982-09-30
YU43097B (en) 1989-02-28
NO850153L (no) 1979-11-27
SE8402887D0 (sv) 1984-05-28
ES480915A1 (es) 1980-02-01
YU123179A (en) 1983-01-21
AT370420B (de) 1983-03-25
CH649556A5 (de) 1985-05-31
IE49173B1 (en) 1985-08-21
LU81319A1 (fr) 1979-09-11
FI67555C (fi) 1985-04-10
AU4742279A (en) 1979-11-29
FI67705C (fi) 1985-05-10
NO155347C (no) 1987-03-18
NL176855B (nl) 1985-01-16
IE49172B1 (en) 1985-08-21
IL59793A0 (en) 1980-06-30
NL7904122A (nl) 1979-11-28
IT1116198B (it) 1986-02-10
ES480914A1 (es) 1980-02-01
FI801609A (fi) 1980-05-19
HK40183A (en) 1983-10-21
NZ193326A (en) 1982-05-31
NO791731L (no) 1979-11-27
PT69669A (en) 1979-06-01
DE2921316C2 (de) 1982-09-16
FI67555B (fi) 1984-12-31
IL57400A (en) 1982-08-31
FR2426695A1 (fr) 1979-12-21
SI7911231A8 (en) 1997-06-30
NZ190558A (en) 1982-05-31
SE438507B (sv) 1985-04-22
US4600772A (en) 1986-07-15
FR2445835B1 (xx) 1983-06-03
FI791678A (fi) 1979-11-27

Similar Documents

Publication Publication Date Title
IL59793A (en) Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(1-pyridinium-methyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them
IL65737A (en) 7-(2-(2-aminothiazol-4-yl)-2-oxy-iminoacetamido)-3-(1-pyridinium)methyl)ceph-3-em-4-carboxylate derivatives and pharmaceutical compositions comprising them
IL51670A0 (en) New alkyloxime derivatives of 7-amino thiazolyl acetamido cephalosporanic acid process for preparing them and pharmaceutical compositions
HK39083A (en) 7-(alpha-oximino-alpha-(2-aminothiazol-4-yl) acetamido) cephalosporanic acid derivatives
AU520657B2 (en) Oxime Derivatives of 3- acetoxy methyl 7-amino thiazolyl acetamido cephalosporanic acid, process for preparing them and pharmaceutical compositions
IL51192A0 (en) New oxime derivatives of 7-amino thiazolyl acetamido cephalosporanic acid process for preparing them and pharmaceutical compositions
IL58717A (en) Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(2-alkyl-pyrazolium-1-ylmethyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them
ZA784187B (en) Crystalline form of the sodium salt of an oxime derivative of 7-amino thiazolyl acetamido cephalosporanic acid,process for preparing it and the pharmaceutical compositions containing it
NZ186998A (en) Esters of cefuroxime ((6r,7r)-3-carbamoyloxy-methyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido) ceph-3-em-carboxylic acid syn isomer) and pharmaceutical compositions
ZA77136B (en) New oxime derivatives of 7-amino thiazolyl acetamido cephalosporanic acid,process for preparing them and pharmaceutical compositions
IL66887A (en) 7-(2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido)-3-pyrazinium-1-ylmethyl)-3-cephem-4-carboxylates,their preparation and pharmaceutical preparations comprising them
ZA781613B (en) New oxime derivatives of 7-amino thiazolyl acetamido cephalosporanic acid,process for preparing them and pharmaceutical compositions
PT71220A (en) Process for the preparation of heterocyclyc derivatives ofoxy-imino-substituted cephalosporins
ES8303424A1 (es) Procedimiento para la obtencion de esteres del acido 7b-(2-(2-animo-4-tiazolil)-2-(sin)-metoxiimino-acetamido)-3-cefem-4-caboxilico.
IL63531A (en) 7-beta-(alpha-syn-methoxyiminoalpha-2(2-aminothiazol-4-yl)-acetamido)-3-((1,2,3-thiadiazol-5-ylthio)methyl)-3-cephem-4-carboxylic acids,their preparation and pharmaceutical compositions comprising them
IL63965A (en) 7-(2-(2-amino-4-selenazoyl)acetamido)cephalosporin derivatives,and intermediates therefor,their preparation and pharmaceutical compositions containing them
ZA781630B (en) New oxime derivatives of 3-acetoxy methyl 7-amino thiazolyl acetamido cephalosporanic acid-process for preparing them and pharmaceutical compositions
IL52709A0 (en) New derivatives of acetamido cephalosporanic acid process for preparing them and pharmaceutical compositions
EP0327358A3 (en) Ceftazidime dihydrochloride formic acid solvates
IL54043A (en) Oxime derivatives of 3-thiadiazolyl thiomethyl 7-amino thiazolyl acetamido cephalosporanic acid,process for preparing them and pharmaceutical compositions comprising them
AU4605279A (en) Oxime derivatives of 3-azidomethyl 7-amino thiazolyl acetamido cephalosporanic acid, their process of preparation and pharmaceutical compositions containing them
PT72173B (en) Process for the preparation of n-substituted thiazolyl derivatives of oxy-imino-substituted cephalosporins
ZA791762B (en) New oxime derivatives of 3-azidomethyl 7-amino thiazolyl acetamido cephalosporanic acid their preocess for preparation and the pharmaceutical compositions containing them
PT75139B (en) Process for the preparation of cephalosporanic acid derivatives and pharmaceutical compositions containing them
ZA772331B (en) New oxime derivatives of 7-amino thiazolyl acetamido cephalosporanic acid,process for their preparation and their application as medicaments